Received Apr 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 945664 | IM / LA |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Y015022 | SC / LA |
Heplisav vaccine was administered into left deltoid. A few minutes passed as immunizer prepared second vaccine. Administration of MMR vaccine into left arm (subcutaneous) was initiated and patient became pale and then unresponsive for a few seconds. Needle was withdrawn before entire dose administered. Patient appeared to lose consciousness for a few seconds (<10). When patient was able to respond to immunizer, he was assisted to elevate his feet and remain seated. Pharmacist provided a cool cloth for patient's face and neck. Patient was full coherent and reported that he felt fine and that this had happened before when he was much younger. Pharmacist remained with patient for about 5 minutes before he was allowed to move to waiting area for further observation. Patient remained at pharmacy for about 20 additional minutes with no additional symptoms.
None reported
None reported
None reported
Age 13, syncope about 20 minutes after unknown vaccine